"Take a Closer Look", page-709

I'm not about to engage you in an ongoing pointless discussion (which we had a long while ago anyway lexcorp) about AHZ's directions. Any comparative examination of Wayne's (as if you were a confidant) experience and mine is irrelevant. I'll say this, I neither know nor care about the minute technical details of Cardiocel - in fact, and this is for your learning benefit, there's an old market adage that says if you have to know that much about a stock then you probably shouldn't be in it....

so I just look at market reactions mostly, and I look at how long it takes for acceptance of a compay's product. Let me give you an example - I'm not cross promoting here - such as ADO. For years the champions of this stock promoted and praised it's 'bio-glue' for want of a better description. It was the answer to everything for them, but I pointed out and repeatedly asked them why, if the product was so great and had been available to the market for years, that there were hardly any sales. Their only answer was abuse directed towards me. Look where ADO is today....

you and many others make another fundamental market error - I'll repeat what I posted on another stock:

Whilst sound science/technology is a necessary condition for commercial success it is not a sufficient condition for commercial success.

and so it is for Admedus. It has many successful rivals. There has been sufficient time now to form the opinion that Cardiocel is not taking the market by storm and probably never will do. And that is the reason why IMO Admedus needs to find another strategy.

I'll leave it there I won't engage in further pointless discussion.